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ABSTRACT
Objective: This study aimed to evaluate the cytotoxic activity of the extracts and fractions of Eriocaulon cinereum against HeLa and Vero cell lines, 
which represent cervical cancer and normal cells, respectively. In addition, a phytochemical screening was carried out to determine the chemical 
constituents in the extracts and the active fractions.
Materials and Methods: The extracts of E. cinereum were obtained by ultrasound-assisted extraction method using n-hexane, ethyl acetate, and 
methanol, successively. The active extract was fractionated using vacuum liquid chromatography with dichloromethane followed by ethyl acetate. The 
cytotoxic activity was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay method and was measured using microplate 
reader at the wavelength 595 nm. The data were analyzed with PROBIT from SPSS 16 for Windows®. In addition, phytochemical screening was 
performed using standard procedures.
Results: The cytotoxic evaluation of the extracts of E. cinereum showed that the ethyl acetate extract was the most active extract against HeLa cell line 
with the half maximal inhibitory concentration (IC50) value of 580.07 μg/ml. The dichloromethane and ethyl acetate fractions from the active extract 
of E. cinereum exhibited cytotoxic activity against HeLa cell with the IC50 values of 466.61 μg/ml and 267.34 μg/ml, respectively. In addition, the ethyl 
acetate fraction showed a low cytotoxic effect against Vero cell line. The phytochemical screening of the ethyl acetate fraction indicated the presence 
of terpenoids and alkaloids.
Conclusion: This finding revealed the anticancer potential of E. cinereum and warranted further investigation for the discovery of new anticancer 
agents from natural resources for cervical cancer.
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INTRODUCTION
Cervical cancer is a cancer commonly caused by the human papilloma 
virus. The World Cancer Report 2014 reported that cervical cancer is 
the fourth most common cause of death in women affected by cancer [1]. 
While in Indonesia, according to the data from the Ministry of Health 
of the Republic of Indonesia, the prevalence of cervical cancer is 0.8% 
of the total population of Indonesia [2]. Therefore, cervical cancer is 
one of the priorities for the Indonesian Ministry of Health in terms of 
combating cancer.
Until now, the most common therapy for patients with cervical cancer 
is a surgery together with a radiotherapy for the early stage of cancer 
or a combination of radiotherapy and chemotherapy for advanced 
stage. The drugs commonly used for chemotherapy in the treatment of 
cervical cancer include cisplatin, carboplatin, paclitaxel, topotecan, and 
gemcitabine [3-7]. However, chemotherapy will cause unwanted side 
effects such as nausea, vomiting, hair loss, mouth sores, fatigue, and 
appetite loss [8].
Nature is known to have a rich source of natural compounds that have 
the health benefits to treat cancer, including the plant from Eriocaulon 
genus. Previous reports showed that some Eriocaulon species have 
the cytotoxic activity. For example, Eriocaulon australe from China 
has cytotoxic activity against A549 lung cancer cells, MCF-7 breast 
cancer cells, and HeLa cervical cancer cells [9]. Meanwhile, Eriocaulon 
sieboldianum was reported to exhibit cancer activity against HL-60 
human leukemia cell line [10] and induce cell cycle arrest of human liver 
cancer cells HepG2 [11]. Furthermore, Fan et al. also reported antitumor 
activity against K562 leukemia cells from E. sieboldianum [12]. In 
addition, E. sieboldianum has been used as adjuvant therapy to treat 
cervical cancer in traditional Chinese medicine [12].
Nugraha et al. [13] conducted a preliminary study to screening the 
Eriocaulon cinereum R.Br. from Bangka Belitung Island, Indonesia, 
for anticancer. This plant has been used by local people to prevent 
and treat uncontrolled cells growth. The result showed the inhibition 
of HeLa cells growth with the half maximal inhibitory concentration 
(IC50) value of 428 µg/mL on ethanol extract [13]. Based on this result, 
further investigation of E. cinereum was carried out as a source for 
new anticancer therapeutics. Therefore, the aims of this study were to 
investigate the cytotoxic activity of the extracts of E. cinereum and its 
fractions against HeLa cells and to identify the phytochemicals present 
in the active extract and fractions.
MATERIALS AND METHODS
Plant materials
The plant was collected from Parittiga, Jebus, Bangka Belitung Island 
Province, Indonesia, on July 2016. E. cinereum R.Br. was identified by 
Drs. Heri Sujadmiko and MSi. from the Laboratory of Plant Systematic 
at Faculty of Biology, Universitas Gadjah Mada, Yogyakarta, Indonesia. 
Voucher specimen was deposited at Laboratory of Pharmaceutical 
Biology, Department of Pharmacy, Universitas Islam Indonesia, 
Yogyakarta, Indonesia (Collection No. BF-FAUII-01). Samples were 
dried using cabinet dryer at 50°C for 36 h and powdered.
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Preparation of plant extracts
The extraction of plant material was done by ultrasound-assisted 
extraction method according to Mandal et al. [14] with some 
modifications. A total weight of 50 g powdered E. cinereum was 
macerated with 500 mL n-hexane using ultrasound-assisted extraction 
method at 40°C for 30 min. After filtering, the filtrate was collected and 
the residue was dried and then extracted 3 times with ethyl acetate 
(500 mL each) using the same method as in the extraction with n-hexane. 
After the third filtering process, the filtrate was again collected, and 
the residue was dried and macerated 3 times with methanol (500 mL 
each) in a similar fashion to the n-hexane maceration procedure. The 
filtrate obtained from each maceration process was concentrated using 
a rotary evaporator to give 0.05 g, 2.52 g, and 2.17 g of n-hexane, ethyl 
acetate, and methanol extracts, respectively.
Fractionation of ethyl acetate extract
The ethyl acetate extract (0.35 g) was fractionated using 
dichloromethane (750 mL) and ethyl acetate (600 mL) using vacuum 
liquid chromatography. The fractions obtained from the fractionation 
processes were evaporated to give dichloromethane (0.136 g) and ethyl 
acetate fractions (0.075 g).
Cell lines and cell cultures condition
HeLa (cervical adenocarcinoma) and Vero (African green monkey 
kidney) cell lines were provided by Parasitology Laboratory, 
Faculty of Medicine, Public Health and Nursing, Universitas Gadjah 
Mada, Yogyakarta, Indonesia. The HeLa cell line was cultured in a 
complete medium consisted of Roswell Park Memorial Institute 1640 
supplemented with 10% fetal bovine serum (FBS), 1% penicillin-
streptomycin, and 0.5% Fungizone (Gibco Amphotericin B), while the 
Vero cell line was cultured in a complete medium consisted of M199 
supplemented with 10% FBS, 2% penicillin-streptomycin, and 0.5% 
Fungizone (Gibco Amphotericin B). Both the cells were incubated at 
37°C in an incubator with 5% CO2.
Cytotoxic evaluation
The extracts and fractions of E. cinereum R. Br. were evaluated with 
HeLa and Vero cell lines to evaluate the cytotoxic activity. HeLa and Vero 
cell lines (each cell with a density of 104 – 5×104 cells/mL) in 100 µL 
complete medium were seeded in 96 well plates. The cell cultures were 
incubated for 24 h in a humidified atmosphere of 5% CO2 at 37°C. 
After incubation, the complete media was discharged from the well 
and the cells were treated with n-hexane extract, ethyl acetate extract, 
and methanol extract of E. cinereum and dichloromethane and ethyl 
acetate fractions from ethyl acetate extract of E. cinereum with various 
concentrations (ranging from 15.625 to 1000 μg/mL). Prior to the 
treatment, the extracts and fractions of E. cinereum were dissolved in 
dimethyl sulfoxide. A series of concentration of 100 µL of extracts and 
100 µL of fractions were applied to the cells then incubated at 37°C in 
5% CO2 incubator for 24 h. The cytotoxicity evaluation was carried out 
using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) assay. 100 µl of 0.5% MTT solution was added to each well of the 
treated suspension cells and then incubated for 4 h at 37°C in 5% CO2 
incubator. After 4 h, the 100 μL sodium dodecylsulphate (SDS) stopper 
(SDS 10% in 0.01 N HCl) was added to each well and further incubated 
at room temperature in a dark place for 24 h. The absorbance was 
measured by the enzyme-linked immunosorbent assay reader (Bio-Rad 
Benchmark Microplate Reader) at 595 nm. The cytotoxicity assay was 
performed in triplicate (n=3).
Phytochemical screening
The n-hexane, ethyl acetate, and methanol extracts of E. cinereum were 
subjected to preliminary phytochemical screening using the standard 
procedures analysis [15] to identify the various chemical constituents.
Qualitative chemical analysis was performed to screen the 
phytochemical contents in dichloromethane and ethyl acetate 
fractions from the ethyl acetate fraction of E. cinereum using thin-layer 
chromatography (TLC) and spray reagents. Fractions were spotted to 
TLC plate silica gel GF254 (Merck) and were eluted with n-hexane:ethyl 
acetate (3:2). The presence of compounds was detected by various 
spray reagents [16,17].
Statistical analysis
All the results of cytotoxic activity were analyzed with PROBIT from 
SPSS 16 for Windows®.
RESULTS
Cytotoxicity activity
To evaluate the cytotoxic activity of the extracts, the MTT assay was 
conducted and the IC50 values of the extracts were determined by 
measuring the concentration of the extract that caused 50% of cell 
population death. As shown at Table 1, the most active extract was the 
ethyl acetate extract with the IC50 value of 580.07 μg/mL, while the 
n-hexane extract showed no cytotoxic activity.
Due to the high cytotoxicity of the ethyl acetate extract, this extract was 
fractionated and evaluated for their cytotoxic activity against HeLa cell 
lines (Table 2). The dichloromethane and ethyl acetate fractions from 
ethyl acetate extract exhibited cytotoxic activity against HeLa cells with 
IC50 values of 466.61 μg/mL and 267.34 μg/mL, respectively. These 
fractions were also tested against Vero cells and showed IC50 values of 
525.95 μg/mL and 795.59 μg/mL, respectively.
Phytochemical screening
The results of phytochemical screening of n-hexane, ethyl acetate, and 
methanol extracts of E. cinereum are displayed in Table 3.
Qualitative screening of the phytochemical content of the active fraction 
from ethyl acetate extract of E. cinereum was carried out with sprayed 
chemical reagents on the eluted sample with TLC. The results of the 
screening are presented in Table 4.
DISCUSSION
E. cinereum is a grass-like herbaceous plant growing in a watery 
swamp area [18]. This species can be found in Bangka Belitung Island, 
Indonesia, and traditionally, this herb is used by the local people for 
cancer prevention. E. cinereum has not been intensively studied for their 
property as anticancer compared to other genus of Eriocaulon [9-12]. 
The finding of the antiproliferative activity of the ethanol extract of 
E. cinereum in HeLa cells from our preliminary study [13] led to our 
further investigation to evaluate the cytotoxic activity of E. cinereum 
against HeLa cell lines.
In the present study, E. cinereum was successively extracted using 
n-hexane, ethyl acetate, and methanol to obtain the relatively nonpolar, 
semipolar, and polar extracts, respectively. The results of the cytotoxicity 
Table 1: The cytotoxic activity of the extracts of Eriocaulon 
cinereum against HeLa and Vero cell lines
Extract HeLa cell IC50 
(μg/mL)
Vero cell IC50 
(μg/mL)
n-hexane extract >1000 >1000
Ethyl acetate extract 580.07±13.09 862.81±41.88
Methanol extract 626.41±14.29 758.21±14.77
IC50: Half maximal inhibitory concentration
Table 2: The cytotoxic activity of the fractions from the ethyl 
acetate extract of Eriocaulon cinereum against HeLa and Vero 
cell lines
Fraction HeLa cell IC50(μg/mL) Vero cell IC50(μg/mL)
Dichloromethane 466.61±34.93 525.95±15.48
Ethyl acetate 267.34±4.19 795.59±8.98
IC50: Half maximal inhibitory concentration
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evaluation of the extracts against HeLa cell showed that the ethyl 
acetate extract was the most cytotoxic with IC50 value of 580.07 μg/ml 
(Table 1). The phytochemical screening showed that the ethyl acetate 
extract of E. cinereum contains flavonoids, alkaloids, terpenoids, and 
steroids (Table 3). Previous chemical analysis reported that E. cinereum 
contains abundant of flavones and isoflavones with major characteristic 
compounds are hispidulin, iristectorigenin A, and irigenin [19]. In 
addition, hispidulin isolated from E. australe demonstrated cytotoxicity 
against Hela cells with IC50 value of 10.38±1.13 μg/ml [9].
The presence of flavonoids in our ethyl acetate extract led the 
assumption that this chemical constituent might contribute in the 
cytotoxic activity against HeLa cells. Therefore, a further investigation 
has been undertaken by fractionated the ethyl acetate extract of 
E. cinereum into dichloromethane and ethyl acetate fraction using 
vacuum liquid chromatography. The results showed that the cytotoxic 
activity of the fractions was higher than the ethyl acetate extract 
(Table 2) with the IC50 values of 466.61 μg/ml and 267.34 μg/ml for 
dichloromethane and ethyl acetate fractions, respectively. Interestingly, 
based on phytochemical screening (Table 4), flavonoids, terpenoids, 
and steroids were detected in the dichloromethane fraction, while 
terpenoids and alkaloids were present in the ethyl acetate fraction. 
This indicated that the cytotoxicity of E. cinereum against HeLa cell 
might be due to the presence of terpenoids and alkaloids instead of 
flavonoids. In addition, the lower cytotoxic activity of dichloromethane 
fraction might be due to the antagonistic effect possessed by the 
presence of other chemical constituents in the fraction which could 
prevent the activity of the flavonoid. Many compounds belonging to 
alkaloids [20-22] and terpenoids [23-25] from different plants have 
been reported for their cytotoxic activity against HeLa cell lines. 
However, to the best of our knowledge, the cytotoxic activity of 
terpenoids and alkaloids from E. cinereum against HeLa cells have not 
been reported yet.
The cytotoxity of the ethyl acetate extract of E. cinereum and its 
fractions to Vero cell lines were also evaluated. The results showed that 
the ethyl acetate extract, dichloromethane fraction, and ethyl acetate 
fraction have a weaker cytotoxicity against Vero cells with IC50 values of 
862.81 μg/ml, 525.95 μg/ml and 795.95 μg/ml, respectively. This study 
indicated that the ethyl acetate fraction might contain compounds with 
a potential cytotoxic activity with a good selectivity and can be further 
developed as anticancer agent. Therefore, a further study is needed to 
identify the secondary metabolites that responsible for the activity and 
the mechanisms of extracts and pure compounds.
CONCLUSION
This study revealed that E. cinereum has the potential to be developed 
as anticancer agent for cervical cervix. The ethyl acetate fraction 
obtained from the ethyl acetate extract of the plant exhibited the most 
potent cytotoxic activity against HeLa cancer cells with low cytotoxicity 
against a normal cell, Vero.
ACKNOWLEDGMENT
This work was supported by the Directorate of Higher Education 
Research Grant on the scheme of Penelitian Dasar Unggulan Perguruan 
Tinggi (Contract no.: 109/SP2H/DRPM/2018). The authors would like 
to thank Dr. Matthew Bertin (University of Rhode Island, USA) and 
Dr. M. Nurul Azmi M.T. (Universiti Sains Malaysia) for proof reading and 
editing the English of the manuscript.
CONFLICTS OF INTERESTS
All authors have none to declare.
REFERENCES
1. Stewart BW, Wild CP, editors. In: World Cancer Report 2014. Lyon: 
International Agency for Research on Cancer; 2014.
2. Kementerian Kesehatan Republik Indonesia. Info Datin: Situasi 
Penyakit Kanker. Pusat Data dan Informasi Kementerian Kesehatan 
RI; 2015. Available from: http://www.depkes.go.id/folder/view/01/
structure-publikasi-pusdatin-info-datin.html. [Last accessed 
on 2017 June 01].
3. Monk BJ, Sill MW, McMeekin DS, Cohn DE, Ramondetta LM, 
Boardman CH, et al. Phase III trial of four cisplatin-containing doublet 
combinations in stage IVB, recurrent, or persistent cervical carcinoma: 
A gynecologic oncology group study. J Clin Oncol 2009;27:4649-55.
4. Katanyoo K, Tangjitgamol S, Chongthanakorn M, Tantivatana T, 
Manusirivithaya S, Rongsriyam K, et al. Treatment outcomes of 
concurrent weekly carboplatin with radiation therapy in locally 
advanced cervical cancer patients. Gynecol Oncol 2011;123:571-6.
5. Li J, Wang LJ, Zhang BZ, Peng YP, Lin ZQ. Neoadjuvant chemotherapy 
with paclitaxel plus platinum for invasive cervical cancer in 
pregnancy: Two case report and literature review. Arch Gynecol Obstet 
2011;284:779-83.
6. Ackermann S, Beckmann MW, Thiel F, Bogenrieder T. Topotecan in 
cervical cancer. Int J Gynecol Cancer 2007;17:1215-23.
7. Mutch DG, Bloss JD. Gemcitabine in cervical cancer. Gynecol Oncol 
2003;90:S8-15.
8. American Cancer Society. Chemotherapy for Cervical Cancer. 
American Cancer Society, Inc.; 2016. Available from: https://www.
Table 3: Preliminary phytochemical screening of various extracts of Eriocaulon cinereum R.Br.
Phytoconstituents Method Extract
n‑hexane Ethyl acetate Methanol
Flavonoids Shinoda test + + +
Zn+HCl test − − +
Alkaloids Dragendorff test − − +
Wagner’s test − − +
Mayer’s test − + +
Saponins Foam test − − +
Terpenoids and Steroids Liebermann’s test + + −
*Positive (+): Present, Negative (−): Absent
Table 4: Phytochemical Screening of ethyl acetate and dichloromethane fractions from ethyl acetate extract of Eriocaulon cinereum R.Br.
Phytoconstituents Spray reagents Fractions
Dichloromethane Ethyl acetate
Flavonoids AlCl3 + −
Alkaloids Dragendorff − +
Terpenoids Anisaldehyde H2SO4 + +
Steroids Liebermann–Burchard + −
*Positive (+): Present, Negative (−): Absent
Int J App Pharm, Vol 11, Special Issue 5, 2019
 Jumaryatno et al. 
 4th International Conference on Pharmacy and Pharmaceutical Science (ICPPS) 2019 93
cancer.org/cancer/cervical-cancer/treating/chemotherapy.html.
[Last accessed on 2017 June 01].
9. Xu Q, Xie H, Wu P, Wei X. Flavonoids from the capitula of Eriocaulon 
australe. Food Chem 2013;139:149-54.
10. Kim SJ, Lee GT, Lee BR, Jeon KS, Rim HK, Bang JH, et al. Anti-
cancer effect of Eriocaulon sieboldianum through the activation of 
caspase-3 in human leukemia cell line, HL-60 cells. Orient Pharm Exp 
Med 2009;9:186-91.
11. Fan Y, Lu H, Ma H, Feng F, Hu X, Zhang Q, et al. Bioactive compounds 
of eriocaulon sieboldianum blocking proliferation and inducing 
apoptosis of hepG2 cells might be involved in aurora kinase inhibition. 
Food Funct 2015;6:3746-59.
12. Fan Y, Lu H, An L, Wang C, Zhou Z, Feng F, et al. Effect of active 
fraction of eriocaulon sieboldianum on human leukemia K562 cells 
via proliferation inhibition, cell cycle arrest and apoptosis induction. 
Environ Toxicol Pharmacol 2016;43:13-20.
13. Nugraha AT, Ramadhan V, Pandapotan H, Romadhonsyah F. A study of 
proliferative activity of herbs Eriocaulon cinereum R. Br. on cervical 
cancer cells (HeLa) with MTT assay method. Int J Pharm Med Biol Sci 
2017;6:73-6.
14. Mandal SC, Mandal V, Das AK. Essential of Botanical Extraction: 
Principles and Application. London: Academic Press; 2015.
15. Jones WP, Kinghorn DA. Extraction of plant secondary metabolites. In: 
Sarker SD, Latif Z, Gray AI, editors. Natural Products Isolation. 2nd ed. 
New Jersey: Humana Press Inc.; 2006. p. 323-51.
16. Jork H, Funk W, Fishcer W, Wimmer H. Thin layer chromatography: 
reagents and detection methods. Weinheim: VCH; 1990. Physical and 
Chemical Detection Methods, Vol. 1a. J Chromatogr 1993;635:176.
17. Harborne JB. Phytochemical Methods: A Guide to Modern Techniques 
of Plant Analysis. 3rd ed. London: Chapman and Hall; 1998.
18. Oliveira ALR, Bove, CP. Eriocaulon L. From Brazil: An annotated 
checklist and taxonomic novelties. Acta Bot Bras 2015;29:175-89.
19. Qiao X, Ye G, Liu CF, Zhang ZX, Tu Q, Dong J, et al. Chemical 
analysis of eriocaulon buergerianum and adulterating species by high-
performance liquid chromatography with diode array detection and 
electrospray ionization tandem mass spectrometry. J Pharm Biomed 
Anal 2012;57:133-42.
20. Mahata S, Bharti AC, Shukla S, Tyagi A, Husain SA, Das BC, et al. 
Berberine modulates AP-1 activity to suppress HPV transcription and 
downstream signaling to induce growth arrest and apoptosis in cervical 
cancer cells. Mol Cancer 2011;10:39.
21. Nair JJ, Rárová L, Strnad M, Bastida J, Cheesman L, van Staden J, et al. 
Crinane alkaloids of the Amaryllidaceae with cytotoxic effects in human 
cervical adenocarcinoma (HeLa) cells. Nat Prod Commun 2014;9:461-6.
22. Li M, Su BS, Chang LH, Gao Q, Chen KL, An P, et al. Oxymatrine 
induces apoptosis in human cervical cancer cells through guanine 
nucleotide depletion. Anticancer Drugs 2014;25:161-73.
23. Momtaz S, Hussein AA, Ostad SN, Abdollahi M, Lall N. Growth 
inhibition and induction of apoptosis in human cancerous HeLa cells 
by Maytenus procumbens. Food Chem Toxicol 2013;51:38-45.
24. Huang J, Han HY, Li GY, Wang HY, Zhang C, Zhang K, et al. Two new 
terpenoid benzoates with antitumor activity from the roots of Ferula 
dissecta. J Asian Nat Prod Res 2013;15:1100-6.
25. Xu X, Yuan J, Zhou X, Li W, Zhu N, Wu H, et al. Cassane diterpenes 
with oxygen bridge from the seeds of Caesalpinia sappan. Fitoterapia 
2016;112:205-10.
